Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Go back to Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
(NASDAQ: CADL) Delayed: 11.21 --0 (-0%)
Previous Close $11.21    52 Week High
Open $11.21    52 Week Low
Day High $11.21    P/E N/A 
Day Low $11.21    EPS
Volume 1,033